mdh.sePublications
Change search
Link to record
Permanent link

Direct link
BETA
Jorsäter Blomgren, KerstinORCID iD iconorcid.org/0000-0002-8793-6084
Publications (8 of 8) Show all publications
Johansson-Pajala, R.-M., Martin, L. & Jorsäter Blomgren, K. (2018). Registered nurses’ use of computerised decision support in medication reviews: Implications in Swedish nursing homes. International Journal of Health Care Quality Assurance, 31(6), 531-544
Open this publication in new window or tab >>Registered nurses’ use of computerised decision support in medication reviews: Implications in Swedish nursing homes
2018 (English)In: International Journal of Health Care Quality Assurance, ISSN 0952-6862, E-ISSN 1758-6542, Vol. 31, no 6, p. 531-544Article in journal (Refereed) Published
Abstract [en]

Purpose: The purpose of this paper is to explore the implications of registered nurses’ (RNs) use of a computerized decision support system (CDSS) in medication reviews. Design/methodology/approach: The paper employs a quasi-experimental, one-group pre-test/post-test design with three- and six-month follow-ups subsequent to the introduction of a CDSS. In total, 11 RNs initiated and prepared a total of 54 medication reviews. The outcome measures were the number of drug-related problems (DRPs) as reported by the CDSS and the RNs, respectively, the RNs’ views on the CDSS, and changes in the quality of drug treatment. Findings: The CDSS significantly indicated more DRPs than the RNs did, such as potential adverse drug reactions (ADRs). The RNs detected additional problems, outside the scope of the CDSS, such as lack of adherence. They considered the CDSS beneficial and wanted to continue using it. Only minor changes were found in the quality of drug treatments, with no significant changes in the drug-specific quality indicators (e.g. inappropriate drugs). However, the use of renally excreted drugs in reduced renal function decreased. Practical implications: The RNs’ use of a CDSS in medication reviews is of value in detecting potential ADRs and interactions. Yet, in order to have an impact on outcomes in the quality of drug treatment, further measures are needed. These may involve development of inter-professional collaboration, such as established procedures for the implementation of medication reviews, including the use of CDSS. Originality/value: This is, to the best of the authors’ knowledge, the first study to explore the implications of medication reviews, initiated and prepared by RNs who use a CDSS. The paper adds further insight into the RNs’ role in relation to quality of drug treatments.

Place, publisher, year, edition, pages
Emerald Group Publishing Ltd., 2018
Keywords
Computerized decision support systems, Drug-related problem, Medication review, Nurse, Nursing home, Pharmacovigilance
National Category
Health Sciences
Identifiers
urn:nbn:se:mdh:diva-40235 (URN)10.1108/IJHCQA-01-2017-0009 (DOI)000436807000009 ()29954263 (PubMedID)2-s2.0-85049225913 (Scopus ID)
Available from: 2018-07-12 Created: 2018-07-12 Last updated: 2019-06-18Bibliographically approved
Holm, L., Ekman, E. & Jorsäter Blomgren, K. (2017). Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Pharmacoepidemiology and Drug Safety, 26(3), 335-343
Open this publication in new window or tab >>Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden
2017 (English)In: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 26, no 3, p. 335-343Article in journal (Refereed) Published
Abstract [en]

Purpose: To investigate how reporting of adverse drug reactions (ADRs) among adults in Sweden is associated to age and sex, in addition to seriousness of the reaction and drug utilisation. Methods: Individual case safety reports (ICSRs) reported by healthcare professionals to the national pharmacovigilance database 2008–2011 were related to defined daily dose (DDD) in the Swedish Prescribed Drug Register (SPDR) for individual’s ≥20 years. Data were stratified into five age groups. Crude and adjusted (by age standardisation of prescribed drugs) reporting rate (RR) and reporting rate ratio was evaluated as well as impact of sex-dependent drugs. Results: Based on 9898 included ICSRs, the crude results show that overall RR was almost similar for both serious and non-serious reports and indicates highest RR in the youngest age group. Women had higher rates than men, with predominance for non-serious reports, contrary to men who had a higher RR of serious ones. Standardisation led partly to the same result, but age-related distribution was adjusted, with highest overall RR in the oldest age groups. Sex-dependent drugs had marginal impact on the results. Conclusion: Age and sex have impact on spontaneous reporting of ADRs. After adjusting for dispensed drugs and by standardisation of age-related differences in prescribed drugs, results indicate that healthcare professionals more frequently reported ADRs for the oldest individuals and for women. Serious reports were more frequently reported for men. 

Place, publisher, year, edition, pages
John Wiley and Sons Ltd, 2017
National Category
Health Sciences
Identifiers
urn:nbn:se:mdh:diva-35172 (URN)10.1002/pds.4155 (DOI)000397301200013 ()28071845 (PubMedID)2-s2.0-85016638948 (Scopus ID)
Available from: 2017-04-13 Created: 2017-04-13 Last updated: 2018-10-16Bibliographically approved
Johansson-Pajala, R.-M., Gustafsson, L.-K., Jorsäter Blomgren, K., Fastbom, J. & Martin, L. (2017). Nurses' use of computerised decision support systems affects drug monitoring in nursing homes. Journal of Nursing Management, 25(1), 56-64
Open this publication in new window or tab >>Nurses' use of computerised decision support systems affects drug monitoring in nursing homes
Show others...
2017 (English)In: Journal of Nursing Management, ISSN 0966-0429, E-ISSN 1365-2834, Vol. 25, no 1, p. 56-64Article in journal (Refereed) Published
Abstract [en]

Aim: To describe variations in nurses' perceptions of using a computerised decision support system (CDSS) in drug monitoring. Background: There is an increasing focus on incorporating informatics into registered nurses' (RNs) clinical practice. Insight into RNs’ perceptions of using a CDSS in drug monitoring can provide a basis for further development of safer practices in drug management. Method: A qualitative interview study of 16 RNs. Data were analysed using a phenomenographic approach. Results: The RNs perceived a variety of aspects of using a CDSS indrug monitoring. Aspects of ‘time’ were evident, as was giving a ‘standardisation’ to the clinical work. There were perceptions of effects of obtained knowledge and ‘evidence’ and the division of ‘responsibilities’ between RNs and physicians of using the CDSS. Conclusion: The RNs perceived a CDSS as supportive in drug monitoring, in terms of promoting standardised routines, team-collaboration and providing possibilities for evidence-based clinical practice. Implications: Implementing a CDSS seems to be one feasible strategy to improve RNs’ preconditions for safe drug management. Nurse managers’ engagement and support in this process are vital for a successful result.

National Category
Medical and Health Sciences Health Sciences
Identifiers
urn:nbn:se:mdh:diva-34691 (URN)10.1111/jonm.12430 (DOI)000393687500007 ()27620980 (PubMedID)2-s2.0-84994045637 (Scopus ID)
Available from: 2017-01-23 Created: 2017-01-23 Last updated: 2018-10-16Bibliographically approved
Johansson-Pajala, R.-M., Jorsäter Blomgren, K., Bastholm-Rahmner, P., Fastbom, J. & Martin, L. (2016). Nurses in municipal care of the elderly act as pharmacovigilant intermediaries: A qualitative study of medication management. Scandinavian Journal of Primary Health Care, 34(1), 37-45
Open this publication in new window or tab >>Nurses in municipal care of the elderly act as pharmacovigilant intermediaries: A qualitative study of medication management
Show others...
2016 (English)In: Scandinavian Journal of Primary Health Care, ISSN 0281-3432, E-ISSN 1502-7724, Vol. 34, no 1, p. 37-45Article in journal (Refereed) Published
Abstract [en]

Objective: To explore registered nurses experience of medication management in municipal care of the elderly in Sweden, with a focus on their pharmacovigilant activities. Design: A qualitative approach using focus-group discussions was chosen in order to provide in-depth information. Data were analysed by qualitative content analysis. Setting: Five focus groups in five different long-term care settings in two regions in Sweden. Subject: A total of 21 registered nurses (RNs), four men and 17 women, aged 27-65 years, with 4-34 years of nursing experience. Results: The findings reveal that RNs in municipal long-term care settings can be regarded as "vigilant intermediaries" in the patients drug treatments. They continuously control the work of staff and physicians and mediate between them, and also compensate for existing shortcomings, both organizational and in the work of health care professionals. RNs depend on other health care professionals to be able to monitor drug treatments and ensure medication safety. They assume expanded responsibilities, sometimes exceeding their formal competence, and try to cover for deficiencies in competence, experience, accessibility, and responsibility-taking. Conclusion: The RNs play a central but also complex role as "vigilant intermediaries" in the medication monitoring process, including the issue of responsibility. Improving RNs possibility to monitor their patients drug treatments would enable them to prevent adverse drug events in their daily practice. New strategies are justified to facilitate RNs pharmacovigilant activities. Key points This study contributes to the understanding of registered nurses (RNs) role in medication management in municipal care of the elderly (i.e. detecting, assessing, and preventing adverse drug events or any drug-related problems).RNs can be considered to be "vigilant intermediaries" in elderly patients drug treatments, working at a distance from staff, physicians, and patients. RNs occasionally take on responsibilities that exceed their formal competence, with the patients best interests in mind. In order to prevent adverse drug events in municipal care of the elderly, new strategies are justified to facilitate RNs pharmacovigilant activities. 

Keywords
Adverse drug event, drug monitoring, elderly, general practice, nurse's role, patient safety, pharmacovigilance, qualitative research, Sweden
National Category
Health Sciences
Identifiers
urn:nbn:se:mdh:diva-31348 (URN)10.3109/02813432.2015.1132891 (DOI)000372023200007 ()26846298 (PubMedID)2-s2.0-84960474361 (Scopus ID)
Available from: 2016-03-24 Created: 2016-03-24 Last updated: 2018-10-16Bibliographically approved
Martin, L., Johansson-Pajala, R.-M., Jorsäter Blomgren, K. & Fastbom, J. (2015). Nurses' self-reported medication competence in relation to their pharmacovigilant activities in clinical practice. Journal of Evaluation In Clinical Practice, 21(1), 145-152
Open this publication in new window or tab >>Nurses' self-reported medication competence in relation to their pharmacovigilant activities in clinical practice
2015 (English)In: Journal of Evaluation In Clinical Practice, ISSN 1356-1294, E-ISSN 1365-2753, Vol. 21, no 1, p. 145-152Article in journal (Refereed) Published
Abstract [en]

Rationale, aims and objectives

Adverse drug reactions (ADRs) represent a major health problem and previous studies show that nurses can have an active role in promoting medication safety. The aim of this study was to describe and evaluate nurses' self-reported competence and pharmacovigilant activities in clinical practice and also to explore the impact of age, education, workplace and nursing experience on these matters.

Methods

This cross-sectional study was based on a questionnaire covering areas related to nurses' medication competence, including knowledge, assessment and information retrieval, and pharmacovigilant activities within these areas, for example, the detection and assessment of ADRs. A 45-item questionnaire was 2013 sent out to 296 nurses in different settings and counties in Sweden. They were selected on the basis of having applied to a university course including pharmacovigilance during 2008–2011. One hundred twenty-four had participated in the courses (exposed) and 172 had applied to the courses but not participated (unexposed).

Results

Completed questionnaires were obtained from 75 exposed (60%) and 93 unexposed (54%) nurses. Overall nurses rated themselves high in medication competence but low in pharmacovigilant activities. Significant (P ≤ 0.001) differences between groups were observed regarding medication competence. The exposure of completed dedicated courses in pharmacovigilance was the strongest factor for self-reported medication competence when adjusted for age, other education, workplace and experience. No significant differences between the groups were found regarding the number of pharmacovigilant activities during the 6 months prior to answering the questionnaire.

Conclusion

Dedicated university courses improved nurses' self-reported competence in pharmacovigilance but did not increase the number of related activities. Education per se seems to be not sufficient to generate pharmacovigilant activities among nurses.

Keywords
education, medication management, nurse, patient safety, pharmacology, pharmacovigilance
National Category
Health Sciences
Research subject
Care Sciences
Identifiers
urn:nbn:se:mdh:diva-26745 (URN)10.1111/jep.12263 (DOI)000350447800021 ()25327625 (PubMedID)2-s2.0-84923613157 (Scopus ID)
Available from: 2014-12-01 Created: 2014-12-01 Last updated: 2018-10-16Bibliographically approved
Holm, L., Ekman, E., Mejyr, S. & Blomgren-Jorsater, K. (2011). Effects of Age and Sex on Adverse Drug Reaction Reporting in Relation to Drug Utilization in Sweden. Paper presented at Supplement: Abstracts 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Hyatt Regency Chicago, Chicago, Illinois, USA August 14–17, 2011. Pharmacoepidemiology and Drug Safety, 20, S117-S117
Open this publication in new window or tab >>Effects of Age and Sex on Adverse Drug Reaction Reporting in Relation to Drug Utilization in Sweden
2011 (English)In: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 20, p. S117-S117Article in journal, Meeting abstract (Other academic) Published
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:mdh:diva-15537 (URN)10.1002/pds.2206 (DOI)000294946600261 ()
Conference
Supplement: Abstracts 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Hyatt Regency Chicago, Chicago, Illinois, USA August 14–17, 2011
Available from: 2012-10-24 Created: 2012-10-10 Last updated: 2017-12-07Bibliographically approved
Sundström, A., Blomgren, K., Alfredsson, L. & Wiholm, B.-E. (2006). Acid – suppressing drugs and gastro-esophageal reflux disease as risk factors for acute pancreatitis – results from a Swedish Case-Control Study.. Pharmacoepidemiology and Drug Safety, 15(3), 141-9
Open this publication in new window or tab >>Acid – suppressing drugs and gastro-esophageal reflux disease as risk factors for acute pancreatitis – results from a Swedish Case-Control Study.
2006 (English)In: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 15, no 3, p. 141-9Article in journal (Refereed) Published
Abstract [en]

PURPOSE: To study risk factors for acute pancreatitis, here with emphasis on gastro-intestinal diseases and their treatments. METHODS: Population based case-control study covering four areas in Sweden encompassing 2.2 million inhabitants. Included were 462 incident cases of acute pancreatitis aged 20-85 years, hospitalized from 1 January 1995-31 May 1998, and 1,781 unmatched controls randomly selected from the study base using a population register. Information was captured from medical records and structured telephone interviews. RESULTS: Current use of H(2) antagonists starting within 6 months of index-date was associated with acute pancreatitis with an adjusted OR of 4.9 (95% confidence interval (CI) 1.6-15), and current use of proton pump inhibitors (PPIs) with an adjusted OR of 3.2 (95%CI 1.4-7.4). For both drug classes, the ORs tended to be higher at higher doses. Gastritis/gastro-esophageal reflux disease (GERD) within the last 12 months not treated with PPIs or H(2)-antagonists and inflammatory bowel disease (IBD) not treated with anti-inflammatory or immunosuppressive drugs were associated with development of acute pancreatitis with adjusted odds ratios (OR) of 1.9 (95%CI 1.2-3.0) and 5.1 (95%CI 2.0-13) respectively. CONCLUSIONS: Current IBD without treatment and gastritis/GERD without treatment were found to be associated with increased risks to develop acute pancreatitis but the nature of the latter association needs to be further evaluated. On balance, we judge that the observed associations between current use of H(2)-antagonists and PPIs and increased risk of acute pancreatitis are unlikely to be explained by bias.

Identifiers
urn:nbn:se:mdh:diva-3511 (URN)10.1002/pds.1137 (DOI)2-s2.0-33645286204 (Scopus ID)
Available from: 2007-06-04 Created: 2007-06-04 Last updated: 2017-12-14Bibliographically approved
Blomgren, K., Sundström, A., Steineck, G. & Wiholm, B.-E. (2006). Interviewer Variability: Quality aspects in a case-control study.. European Journal of Epidemiology, 21(4), 267-277
Open this publication in new window or tab >>Interviewer Variability: Quality aspects in a case-control study.
2006 (English)In: European Journal of Epidemiology, ISSN 0393-2990, Vol. 21, no 4, p. 267-277Article in journal (Refereed) Published
Abstract [en]

Quality assurance and quality control are important for the reliability of case-control studies. Here we describe the procedures used in a previously published study, with emphasis on interviewer variability. To evaluate risk factors for acute pancreatitis, information including previous diagnoses and medication was collected from medical records and by telephone interviews from 462 cases and 1781 controls. Quality assurance procedures included education and training of interviewers and data validity checks. Quality control included a classification test, annual test interviews, expert case validation, and database validation. We found pronounced variations between interviewers. The maximal number of interviews per day varied from 3 to 9. The adjusted average (95% CI) number of diagnoses captured per interview of cases was 4.1 (3.8-4.3) and of controls 3.5 (3.4-3.7) (excluding one deviating interviewer). For drugs, the average (95% CI) number per interview was 3.9 (3.7-4.1) for cases and 3.3 (3.2-3.4) for controls (excluding one deviating interviewer). One of the fourteen interviewers deviated significantly from the others, and more so for controls than for cases. This interviewer's data ;were excluded. Nonetheless, data concerning controls more frequently needed correction and supplementation than for cases. Erroneous coding of diagnoses and medication was also more frequent among controls. Thus, a system for quality control of coding practices is crucial. Variability in interviewers' ability to ascertain information is a possible source of bias in interview-based case-control studies when "blinding" cannot be achieved.

National Category
General Practice
Identifiers
urn:nbn:se:mdh:diva-3512 (URN)10.1007/s10654-006-0017-7 (DOI)000237467700004 ()2-s2.0-33646541657 (Scopus ID)
Available from: 2007-06-04 Created: 2007-06-04 Last updated: 2018-01-13Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-8793-6084

Search in DiVA

Show all publications